0001209191-21-070768.txt : 20211221 0001209191-21-070768.hdr.sgml : 20211221 20211221160847 ACCESSION NUMBER: 0001209191-21-070768 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211220 FILED AS OF DATE: 20211221 DATE AS OF CHANGE: 20211221 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dulac Edward J III CENTRAL INDEX KEY: 0001821530 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36076 FILM NUMBER: 211509245 MAIL ADDRESS: STREET 1: FATE THERAPEUTICS, INC. STREET 2: 3535 GENERAL ATOMICS COURT STE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: FATE THERAPEUTICS INC CENTRAL INDEX KEY: 0001434316 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 651311552 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12278 SCRIPPS SUMMIT DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92131 BUSINESS PHONE: 858.875.1803 MAIL ADDRESS: STREET 1: 12278 SCRIPPS SUMMIT DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92131 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-12-20 0 0001434316 FATE THERAPEUTICS INC FATE 0001821530 Dulac Edward J III C/O FATE THERAPEUTICS, INC. 12278 SCRIPPS SUMMIT DRIVE SAN DIEGO CA 92131 0 1 0 0 Chief Financial Officer Common Stock 2021-12-20 4 M 0 14437 35.52 A 126381 D Common Stock 2021-12-20 4 S 0 15977 60.00 D 110404 D Stock Option (Right to Buy) 35.52 2021-12-20 4 M 0 14437 0.00 D 2030-08-17 Common Stock 14437 128238 D This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on June 28, 2021. The option shall vest as to 25% of the underlying shares on August 17, 2021 and thereafter on a monthly basis for 36 additional months, subject to the Reporting Person's continuous service to the Issuer as of each such vesting date. /s/ Cindy Tahl, as Attorney-in-Fact 2021-12-21